4//SEC Filing
Tardio Jason 4
Accession 0001209191-24-003972
CIK 0001636651other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 6:05 PM ET
Size
7.7 KB
Accession
0001209191-24-003972
Insider Transaction Report
Form 4
Tardio Jason
Chief Commercial Officer
Transactions
- Award
Common Stock
2024-02-22+28,125→ 28,125 total - Award
Stock Option (Right to Buy)
2024-02-22+168,750→ 168,750 totalExercise: $3.68Exp: 2034-02-21→ Common Stock (168,750 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit (RSU) award. One-third (1/3) of the total number of RSUs shall vest on January 1, 2025 and one-third (1/3) of the remaining RSUs shall vest each year thereafter on anniversary of the vesting commencement date, subject to the Reporting Person's continuous service through such vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Common Stock.
- [F3]25% of the shares subject to the Stock Option will vest and become exercisable on February 22, 2025 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued services through such date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001794698
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 6:05 PM ET
- Size
- 7.7 KB